daily market
intelligence service for the cardiology device industry from the publishers of
- Daily email alerts featuring the latest cardiology device industry news
- 25 issues of Clinica Cardiology in a user-friendly format, available as a 16-page print or PDF
- A fully searchable archive of articles dating back to January 2007
-
TCT 2007: Endeavour stent creeps closer to US approval after study boost
Endeavor, Medtronic's zotarolimus-eluting coronary stent, is as safe and effective as Boston Scientific's paclitaxel-coated stent, Taxus. So claimed Medtronic at the Transcatheter Cardiovascular Therapeutics (TCT) meeting, held in Washington, DC, on October 22.
Read more... -
Icon bags Ariad's derforolimus for drug-eluting stent:
Emerging cardiovascular company Icon Medical has secured access to Ariad Pharmaceuticals' mTOR protein-inhibitor, deforolimus, which it will use to develop drug-eluting stents for vascular disease.
Read more... -
Boston axes 13% of workforce as part of major cost-cutting
Boston Scientific is set to give its ailing finances a boost with the introduction of several major restructuring and cost-cutting initiatives.
Read More...
-
Latest Industry News
Gain an insider's view into the latest news on companies, regulations, product launches and recalls, scientific developments, senior appointments and upcoming industry events. -
Market Sector Profiles
Plan your product strategy with detailed market sector profiles on the major product sectors, including:
- Cardiac rhythm management
- Cardiac surgery
- Imaging and diagnostics
- Interventional cardiology
Each profile contains market size data, forecasts to 2011, technological developments, end-user trends, company activity and market analysis. -
Company Profiles
Assess your key competitors and avoid the pitfalls of others using the in-depth company profiles on companies such as Abbott, Johnson & Johnson, St Jude Medical, Medtronic, Abiomed.
Each company profile covers financial data, recent acquisitions, major milestones and new products.
-
Cardiosolutions raises $7m in series A
Heart repair specialist Cardiosolutions has secured $7m in a series A convertible preferred stock financing round...
Read more... -
Medtronic hit by defib lead crisis after "very serious" Fidelis recall
Medtronic's flagging defibrillator business has suffered a major setback with the discovery of a potentially fatal defect led to the firm suspending shipments of a best-selling defibrillation lead..
Read more...